Professional
Added to YB: 2025-10-30
Pitch date: 2025-09-30
RVTY [bullish]
Revvity, Inc.
+13.25%
current return
Author Info
No bio for this author
Company Info
Revvity, Inc. provides health sciences solutions, technologies, and services. The company provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services; and instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Market Cap
$10.5B
Pitch Price
$87.48
Price Target
N/A
Dividend
0.30%
EV/EBITDA
15.05
P/E
47.57
EV/Sales
4.60
Sector
Life Sciences Tools and Services
Category
value
Diamond Hill Mid Cap Strategy New Position: Revvity, Inc.
RVTY (new position): Life sciences tools & diagnostics co providing instruments/consumables for preclinical drug research. Upgraded product portfolio to higher-margin offerings. Added position at discount to intrinsic value amid biopharma policy uncertainty concerns.
Read full article (1 min)